UniSuper Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.62M Buy
19,192
+363
+2% +$119K 0.04% 236
2025
Q4
$6.6M Sell
18,829
-3,592
-16% -$1.21M 0.04% 206
2025
Q3
$7.24M Buy
22,421
+6,496
+41% +$2.02M 0.04% 207
2025
Q2
$6.19M Sell
15,925
-59
-0.4% -$23.7K 0.04% 206
2025
Q1
$6.95M Buy
15,984
+467
+3% +$187K 0.05% 180
2024
Q4
$5.72M Sell
15,517
-9,984
-39% -$4.18M 0.04% 205
2024
Q3
$13.3M Buy
25,501
+14,497
+132% +$7.74M 0.1% 139
2024
Q2
$5.96M Buy
11,004
+5,951
+118% +$3.15M 0.05% 191
2024
Q1
$2.62M Buy
5,053
+3,114
+161% +$1.55M 0.03% 220
2023
Q4
$914K Sell
1,939
-1,607
-45% -$743K 0.01% 269
2023
Q3
$1.54M Sell
3,546
-425
-11% -$193K 0.02% 238
2023
Q2
$1.76M Buy
+3,971
New +$1.83M 0.02% 235

Other funds holding ELV

UniSuper Management's ELV Position: Q1 2026 in Review

UniSuper Management increased its Elevance Health (ELV) stake by 1.9% in Q1 2026, buying an estimated $119K and bringing the position to 19,192 shares worth $5.62M. The position accounts for 0.04% of the portfolio, ranked #236.

UniSuper Management first reported a position in ELV in Q2 2023 and has held it in 12 quarters since. The position peaked at $13.3M in Q3 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • UniSuper Management held 19,192 shares of Elevance Health worth $5.62M as of Q1 2026.
  • UniSuper Management bought 363 Elevance Health shares in Q1 2026, an estimated $119K.
  • Elevance Health made up 0.04% of UniSuper Management's portfolio in Q1 2026, its #236 holding.
  • UniSuper Management first reported a position in Elevance Health in Q2 2023 and has held it in 12 quarters since.
  • UniSuper Management's Elevance Health position peaked at $13.3M in Q3 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on UniSuper Management's 13F filing for Q1 2026, filed 11 May 2026.